KARUNA THERAPEUTICS
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.
KARUNA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.karunatx.com
Total Employee:
101+
Status:
Active
Contact:
6174823337
Email Addresses:
[email protected]
Total Funding:
1.12 B USD
Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Current Employees Featured
Founder
Stock Details
Investors List
PureTech Health
PureTech Health investment in Series B - Karuna Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Karuna Therapeutics
Partner Fund Management
Partner Fund Management investment in Series B - Karuna Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Karuna Therapeutics
Sands Capital Ventures
Sands Capital Ventures investment in Series B - Karuna Therapeutics
Wellcome Trust
Wellcome Trust investment in Series B - Karuna Therapeutics
Eventide
Eventide investment in Series B - Karuna Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Karuna Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Karuna Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Karuna Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-11-29 | Karuna Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer |
Official Site Inspections
http://www.karunatx.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.87 K
- Host name: 165.89.235.72
- IP address: 165.89.235.72
- Location: Trenton United States
- Latitude: 40.2187
- Longitude: -74.7404
- Metro Code: 504
- Timezone: America/New_York
- Postal: 08629

More informations about "Karuna Therapeutics"
Bristol Myers Squibb Strengthens Neuroscience Portfolio with ...
Dec 22, 2023 [email protected]. Source: Bristol Myers Squibb. Media downloads: 706 x 98 jpg 27 KB. Download original jpg 27 KB 706 x 98. Download thumbnail png 5 KB 200 x 28. โฆSee details»
Karuna Therapeutics - Crunchbase Company Profile
Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological โฆSee details»
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.See details»
Karuna Therapeutics Submits New Drug Application to U.S. Food โฆ
Sep 28, 2023 Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people livSee details»
Bristol Myers Squibb Strengthens and Diversifies Presence in ...
Additional Information and Where to Find it In connection with the proposed acquisition of Karuna Therapeutics by Bristol Myers Squibb, Karuna Therapeutics intends to file a preliminary and โฆSee details»
Bristol Myers Squibb to Acquire Karuna Therapeutics
Additional Information and Where to Find it In connection with the proposed acquisition of Karuna Therapeutics by Bristol Myers Squibb, Karuna Therapeutics intends to file a preliminary and โฆSee details»
News Release Details - PureTech Health
Nov 29, 2023 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โฆSee details»
Karuna Therapeutics Announces The Lancet Publication of Data โฆ
BOSTON, December 14, 2023--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines โฆSee details»
Karuna Therapeutics Announces U.S. Food and Drug โฆ
BOSTON, November 29, 2023--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines โฆSee details»
Karuna Therapeutics Reports Third Quarter 2023 Financial Results โฆ
Nov 2, 2023 A webcast of the live call may be accessed on the Investor Relations page of Karunaโs website at investors.karunatx.com. A replay of the webcast will be available for up to โฆSee details»
Karuna Therapeutics Submits New Drug Application to U ... - Zai โฆ
Sep 28, 2023 It represents the culmination of years of pre-clinical and clinical development, and a great deal of skill and hard work by our R&D organization. Our priorities over the next year โฆSee details»
Karuna Therapeutics Reports First Quarter 2023 ... - Business Wire
May 4, 2023 A webcast of the live call may be accessed on the Investors section of the Karuna website at investors.karunatx.com. A replay of the webcast will be available for up to 30 days โฆSee details»
PureTech Founded Entity Karuna Therapeutics to be Acquired by โฆ
PureTech is a founder of Karuna and co-inventor of the KarXT program. If approved, KarXT will be the third therapeutic candidate to be taken from inception at PureTech to FDA regulatory โฆSee details»
Schizophrenia - Bristol Myers Squibb
Although many people living with schizophrenia have difficulty finding an effective treatment, with the help of a dedicated care team,it is possible for people withSee details»
Karuna Therapeutics Announces U.S. Food and Drug ... - Zai Lab
May 30, 2024 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โฆSee details»
News Release Details - PureTech Health
Mar 20, 2023 For more information, please visit www.karunatx.com. Forward-Looking Statements. This press release contains forward looking statements within the meaning of โฆSee details»
Karuna Therapeutics Announces Leadership Appointments
Aug 3, 2023 Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for peopleSee details»
Schizophrenia - Karuna
Although many people living with schizophrenia have difficulty finding an effective treatment, with the help of a dedicated care team, it is possible for people with schizophrenia to live full lives.See details»
Karuna Therapeutics Announces Positive Results from Phase 1b โฆ
Nov 17, 2023 For more information, please visit www.karunatx.com. Forward Looking Statements . This press release contains forward looking statements within the meaning of โฆSee details»
Karuna Therapeutics Reports Second Quarter 2022 ... - Business Wire
Aug 8, 2022 The increase in net loss for the quarter was driven by research and development expenses related to the Companyโs enrollment of the Phase 3 EMERGENT and ARISE trials, โฆSee details»